Autoinflammatory disorders are characterized by spontaneous episodes of systemic inflammation deriving from inherited defects of the innate immune system. Childhood is usually the lifetime involved in most inherited autoinflammatory disorders, but a moderate number of patients may experience disease onset during adulthood. Herein we report our experience in the clinical and genetic approach to the diagnosis of autoinflammatory disorders in regard of the first 500 pediatric and adult patients evaluated during the period 2007-2012 in our Center, due to histories of periodically-recurring inflammatory attacks, giving emphasis to the differences observed according to patients'age and to the most relevant data differentiating child and adult-onset autoinflammatory disorders in the medical literature.
n INTRODUCTION A utoinflammatory disorders (AID) are a newly recognized expanding group of hereditary monogenic diseases in which systemic inflammation recurs without any auto-reactive T-lymphocytes or auto-antibodies, caused by dysfunction of the inflammasome (1) . The inflammasome, a multiprotein complex regulating the release of caspase activation-dependent cytokines, represents an alert sentry of the innate immune system and all AID are characterized by dysregulated production of proinflammatory cytokines, released by the inflammasome, such as interleukin (IL)-1β. The inflammatory flare, often triggered by an unknown stimulus, results in periodically-recurring symptoms with variable involvement of skin, joints, gastrointestinal tube, serosal membranes, or central nervous system: nevertheless each flare is separated by symptom-free intervals of variable duration (2) . Understanding the genetics behind AID has led to the discovery of new molecules involved in the inflammatory response to different exogenous and endogenous signals, but no formal guidelines for the approach of patients with AID exist both for children and adults. To leave aside these patients might lead to renal AA amyloidosis, the best-known and ominous long-term complication of AID, with a prevalence ranging from 2 to 25% for the different clinical entities (3) . Apart from lifelong recurrent flares, AID have distinctive features, such as age of onset, prognosis and ethnic origin of patients, but the differential diagnosis remains a challenge and genetic analysis might only in part contribute to diagnosis. A host of multi-factorial disorders, such as Behçet disease, gout, adult Still's disease, systemic-onset juvenile idiopathic arthritis, and periodic fever/aphthosis/pharyngitis/ adenitis (PFAPA) syndrome, are nowadays deemed as acquired AID on a potential polygenic basis (4) and must be taken in consideration in the differential diagnosis of AID. 
The experience of our Center
The list of monogenic AID attended in our tertiary referral Center includes familial Mediterranean fever (FMF), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), mevalonate kinase deficiency syndrome, also known as hypergammaglobulinemia-D syndrome (HIDS), the whole family of cryopyrin associated periodic syndromes (CAPS), which encompass familial cold urticaria syndrome (FCAS), Muckle-Wells syndrome and chronic infantile neurological cutaneous and articular syndrome (CINCAs), and also NLRP12-associated autoinflammatory disorder (NLRP12AD) and Blau syndrome (BS). Table I summarizes the main clinical characteristics of these AID. The advent of genetic testing for AID has led to the identification of specific disea- Figure 1 shows the percentages of AID diagnosed with differences between patients older and younger than 18 years. The histogram showed in Figure 2 describes the number of AID diagnoses made among patients with more or less than 18 years for each disease among all patients undergoing genetic analysis. The histogram showed in Figure 3 describes the number of patients with more or less than 18 years who un- Figure 4 shows the total number in regard to age of patients undergoing genetic analysis during the same 2007-2012 period. Figure 5 shows the annual percentages of genetically positive patients compared to the total number of subjects genetically evaluated per year. At last, Figure 6 depicts the number of genes evaluated in the period 2007-2012, among patients with more or less than 18 years for a total of 857 genes evaluated. The gene/patient ratio was 1.67. Many reflections can be drawn by reading these figures, combined with comparisons with data differentiating child and adultonset AID in the medical literature.
What we have found and what is known about child and adult-onset autoinflammatory disorders
With regard to FMF, more than 60% of patients have a disease onset before age 10, but onset occurs before age 30 in 98% of patients, and before age 50 in the remaining 2% (5) . A delayed onset has frequently been reported in FMF (6, 7). Adult-onset FMF seems to be related to heterozigosity and low-penetrance mutations: although adults often experience a milder phenotype, clinical features might be similar to those found in younger patients, except for a lower rate of arthritides and erysipelaslike rash. Establishing promptly FMF diagnosis allows to set up its mainstream treatment, based on the oral administration of colchicine (8) . Although the Tel Hashomer criteria are mostly useful in diagnosing adult patients with FMF, a new set of criteria studied in a cohort of Turkish children has showed a higher sensitivity and specificity for the diagnosis of FMF in childhood (9) . A clinical diagnosis can be confirmed by MEFV mutations, but adult-onset FMF patients may sometimes show an incomplete clinical picture and these subjects will never fulfil the currently used diagnostic criteria, requiring genetic testing as a crucial point to the diagnosis (10 TRAPS is the most variable and protean entity among AID in terms of age of disease onset, frequency, duration and severity of inflammatory flares, and this heterogeneity is probably linked to the wide spectrum of TNFRSF1A mutations (18, 19) . The average age of TRAPS onset is around 3 years, but adult-onset up to the sixth decade has been reported as well (18) . As with FMF, it is frequently related to low-penetrance mutations. The majority of children with an R92Q TNFRSFA1 mutation show a milder disease course than that in children with structural mutations and have a higher rate of spontaneous resolution or amelioration of the recurrent fever episodes (20 (25) . Recently, we suggested that difficult-totreat pericarditis and lack of spontaneous amelioration of symptoms after the first year from the first attack of pericarditis may represent further reasons to investigate for TNFRSF1A (26) . We have more recently identified some variables strongly related to the probability of detecting mutations in the MEFV and TNFRSF1A genes (16) , and also validated a diagnostic score for identifying patients at high risk to carry these mutations according to clinical manifestations, age of disease-onset, and family history (14, 15) : the score may serve in the initial diagnostic evaluation of adults presenting with recurrent fever episodes, helping to identify those subjects who may be carriers of MEFV and TNFRSF1A mutations. However, before it can be recommended for a large application, further evaluation is needed by means of longitudinal studies on people of different ethnicities and living in non-Mediterranean areas. HIDS is typically characterized by onset in the first year of life, and MVK genetic testing appears not indicated in patients who have their first fever attack after 5 years (27) . All our patients tested for MVK had their first clinical manifestations starting in early childhood. Clinical data obtained from 103 patients of 18 different countries showed that the median age of the first attack was 6 months, with a median period of 9.9 years from onset of disease to diagnosis, that the most frequent symptoms other than fever were lymphadenopathy, abdominal pain, arthralgia, diarrhea, vomiting, skin lesions, and aphthous ulcers, and that the frequency of attacks decreased with the patient's increasing age (28) . Also CAPS, based on elevated IL-1β overproduction, start in early childhood with most patients presenting periodic fever, skin rash, osteoarthropathy, and risk of aseptic meningitis, sensorineural hearing loss, and optic neuritis (29): even CINCAs, the most severe form of CAPS with neurologic involvement, if properly recognized in children, might show sensational responses to IL-1 antagonists (30).
We have recently described a case series of patients presenting with FCAS-like symptoms, mainly worsened by cold exposure, and carrying the low-penetrance Q703K mutation in the NLRP3 gene, most of whom were characterized by adult-onset disease (31) . In agreement with these findings, we have recently diagnosed a Caucasian mother and her daughter with FCAS: both these patients carried the lowpenetrance V198M mutation in the NLRP3 gene and displayed the clinical onset during adulthood, with clinical manifestations triggered by generalized cold exposure (unpublished data). Also patients with NLRP12AD suffer from early infancy-onset recurrent bouts of fever, joint symptoms, and skin rash triggered by cold exposure (32) . However, Borghini et al. have recently described a 32-year-old woman as a carrier of the D294E mutation in the NLRP12 gene, and this patient experienced FCAS-like symptoms since she was 20 (33) . In agreement with this report, we recently diagnosed a 27-year-old Caucasian woman with NLRP12AD, carrying the F402L mutation, who presented a daily low-grade fever (<38°C) since the age 22, confirming that a subset of NLRP12-mutated patients might display onset-symptoms during adulthood (unpublished data). BS is phenotypically characterized by granulomatous polyarthritis with boggy synovial effusions and cysts, uveitis and persistent dermatitis with scaly or lichenoid features, starting before 4 years, but its diagnosis is often overlooked or postponed due to the poor knowledge of the syndrome among clinicians (34) . In our Center we have tested 28 patients for mutations in the gene responsible for BS. Thirteen out of 28 were children and 3 of them were genetically positive. Fifteen adults were suspected of being affected with a previously undiagnosed BS, but no mutations were found. Differential diagnosis of AID can also be complicated by other challenging acquired entities, as PFAPA syndrome (35): to date, this disorder does not have a documented genetic basis, and spontaneous resolution of febrile flares is usually observed a few years later its onset, mostly in pediatric patients. Controversy exists about differentiation between patients with PFAPA syndrome and other established monogenic AID: a diagnostic score has been formulated on the basis of a statistical analysis in 173 children with periodic fevers and PFAPA-like symptoms, analyzed for MEFV, TNFRSF1A, and MVK genotypes, disclosing that age at onset, positive family history, thoracic or abdominal pain, diarrhea, and oral aphthosis were the variables predicting the probability of a positive genetic test result for hereditary AID with an overall accuracy of 66% (36, 37) . Recent medical literature has involved dozens of suspected cases of PFAPA syndrome also in adults of different age (38) (39) (40) . As patients with PFAPA syndrome develop predictable and stereotypic febrile attacks occurring approximately every 4 weeks, with aphthous stomatitis, exudative or nonexudative pharyngitis, cervical lymph node enlargement, and even abdominal or skin signs, they pose diagnostic challenges with regards to FMF, as the clinical features might overlap between the two conditions. It has been established that the frequency of PFAPA syndrome-like findings tends to decrease from patients with FMF having a single low-penetrance mutation towards those with two high-penetrance mutations (41) . In conclusion, although AID are mostly characterized by onset occurring in childhood, both delayed diagnosis during adulthood and adult-onset symptoms are commonly encountered. Adulthood-onset AID might be related in most cases to the presence of low-penetrance mutations, generating a nonspecific and nuanced phenotype in comparison with children. Low-penetrance mutations may also be responsible for incomplete or mild disease patterns in some cases, and for the appearance of atypical manifestations in other cases. The increasing reports of adult patients are shedding a new light on the protean clinical scenery, genotype-phenotype correlations, overall prognosis and therapeutic management of AID, but a specific diagnosis will still require a thorough clinical examination, family history, ethnic origin, and laboratory evaluation combined with focused genetic analysis. 
